Institut Català de la Salut   Report issue

Academic/Hospital Phase 3
Founded: Barcelona Spain (1983)

Organization Overview

First Clinical Trial
2015
NCT02663245
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

INSTITUT CATALA DE LA SALUT | Institut Català de la Salut

Active Ingredients

Drugs in Phase 3 Trials (1)

montelukast (singulair) (1 trial)

Drugs in Other Trials (1)

cocoa powder (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Signs and Symptoms, Respiratory (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2